News | May 19, 2011

Cheetah Medical's Noninvasive Hemodynamic Monitoring Technology Found to be a Highly Accurate and Promising Tool in Patients With Pulmonary Hypertension

May 19, 2011 - Results from a study validating Cheetah Medical's noninvasive NICOM system specifically for use in patients with pulmonary hypertension were presented Wednesday, May 18th, at the 2011 American Thoracic Society Annual Meeting in Denver.

Pulmonary hypertension (PH) is a life threatening condition that affects the heart and lungs. The cause is gradual narrowing of the lung's arteries, which severely impedes blood to flow normally from the heart through the lungs. This means the heart has to work harder than normal to push the blood through the lungs. Over time, the heart weakens and cannot keep up so that blood flow decreases. Eventually, the heart becomes so weak that it can't pump enough blood to meet the demands of the body, even at rest, which leads to the debilitating symptoms of heart failure such as shortness of breath at rest or during minimal activity (for example, climbing two flights of stairs), tiredness, swelling of the legs and stomach, and palpitations (abnormal heartbeats).
Clinicians have been seeking better ways to monitor disease progression in order to refine treatment. However, traditional methods to assess patients' hemodynamic parameters, and most notably patients' cardiac output (CO), are highly invasive and thus suboptimal for routine serial assessment of PH.

In this study, the Cheetah Medical NICOM (Noninvasive Cardiac Output & Hemodynamic Monitoring System) was used to monitor the hemodynamic performance of 25 pulmonary hypertension patients. University of Chicago researchers compared the results obtained with NICOM to those obtained with two gold-standard methods, which are also invasive: the pulmonary artery catheter, also known as Swan-Ganz catheter, and the Fick method. The NICOM system provided equally accurate and precise measurements to the standard methods, but was completely non-invasive.

Stuart Rich, MD, professor of medicine at the University of Chicago and the study's principal investigator, said, "Survival in patients with pulmonary hypertension is closely linked to their cardiac output. However, because cardiac output measurements have required invasive cardiac catheterization, patients do not have this measured often. With the validation of a simple noninvasive technique to measure cardiac output in these patients, physicians should now be able to evaluate their patients' status frequently, and better judge the efficacy of their treatments."

Researchers hope that these findings will encourage use of CO monitoring not only into routine clinical practice to provide objective means of tracking changes in disease status and response to therapy, but will also pave the way to explore the utility of this technique in clinical trials as an early screening tool for differentiating effective versus non-effective treatments for PH.

For more information: www.cheetah-medical.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC| September 07, 2017
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of
Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Text Messaging Could Help Tackle High Blood Pressure in At-Risk Patients

Image courtesy of Michigan Medicine

News | Hypertension| September 06, 2017
A new National Institutes of Health-funded hypertension trial will examine the possibility of using an emergency...
Advances in FFR, FFR-CT, was the most popular cardiology story in August 2017.

The most popular article in August was about advances in fractional flow reserve (FFR) technologies. The image shows Philips' new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions.

Feature | September 01, 2017 | Dave Fornell
September 1, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional Car
Overlay Init